Brain cyclooxygenase-2 mediates interleukin-1-induced cellular activation in preoptic and arcuate hypothalamus, but not sickness symptoms

Neurobiology of Disease

Volumn 39, Issue 3, 2010, Pages 393-401

  Nadjar, Agnès ^a   Sauvant, Julie ^a   Combe, Chantal ^a   Parnet, Patricia ^a   Konsman, Jan Pieter ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Anorexia; Arcuate hypothalamus; C Fos; Corticosterone; Cyclooxygenase 2; Extracellular signal regulated kinase; Fever; Interleukin 1; Preoptic Hypothalamus; Prostaglandin

Indexed keywords

CORTICOSTERONE; CYCLOOXYGENASE 2; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROTEIN C FOS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOREXIA; ARCUATE HYPOTHALAMUS; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FEVER; HYPOTHALAMUS; IMMUNOREACTIVITY; MALE; MICROSCOPY; NEUROENDOCRINE SYSTEM; NONHUMAN; PREOPTIC AREA; PRIORITY JOURNAL; PROTEIN INDUCTION; RAT;

EID: 77954953194     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2010.05.005     Document Type: Article

References (55)

1. Andreis P.G., Neri G., Belloni A.S., Mazzocchi G., Kasprzak A., Nussdorfer G.G. Interleukin-1 beta enhances corticosterone secretion by acting directly on the rat adrenal gland. Endocrinology 1991, 129:53-57.
2. Anforth H.R., Bluthe R.M., Bristow A., Hopkins S., Lenczowski M.J., Luheshi G., Lundkvist J., Michaud B., Mistry Y., Van Dam A.M., Zhen C., Dantzer R., Poole S., Rothwell N.J., Tilders F.J., Wollman E.E. Biological activity and brain actions of recombinant rat interleukin-1alpha and interleukin-1beta. Eur. Cytokine Netw. 1998, 9:279-288.
3. Bernton E.W., Beach J.E., Holaday J.W., Smallridge R.C., Fein H.G. Release of multiple hormones by a direct action of interleukin-1 on pituitary cells. Science 1987, 238:519-521.
4. Bluthe R.M., Dantzer R., Kelley K.W. Effects of interleukin-1 receptor antagonist on the behavioral effects of lipopolysaccharide in rat. Brain Res. 1992, 573:318-320.
5. Burkey T.H., Regan J.W. Activation of mitogen-activated protein kinase by the human prostaglandin EP3A receptor. Biochem. Biophys. Res. Commun. 1995, 211:152-158.
6. Cao C., Matsumura K., Yamagata K., Watanabe Y. Endothelial cells of the rat brain vasculature express cyclooxygenase-2 mRNA in response to systemic interleukin-1 beta: a possible site of prostaglandin synthesis responsible for fever. Brain Res. 1996, 733:263-272.
7. Ching S., Zhang H., Belevych N., He L., Lai W., Pu X.A., Jaeger L.B., Chen Q., Quan N. Endothelial-specific knockdown of interleukin-1 (IL-1) type 1 receptor differentially alters CNS responses to IL-1 depending on its route of administration. J. Neurosci. 2007, 27:10476-10486.
8. Copeland R.A., Williams J.M., Giannaras J., Nurnberg S., Covington M., Pinto D., Pick S., Trzaskos J.M. Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:11202-11206.
9. Davidson J., Abul H.T., Milton A.S., Rotondo D. Cytokines and cytokine inducers stimulate prostaglandin E2 entry into the brain. Pflugers Arch. 2001, 442:526-533.
10. Desai S., Ashby B. Agonist-induced internalization and mitogen-activated protein kinase activation of the human prostaglandin EP4 receptor. FEBS Lett. 2001, 501:156-160.
11. Durand M., Berton O., Aguerre S., Edno L., Combourieu I., Mormede P., Chaouloff F. Effects of repeated fluoxetine on anxiety-related behaviours, central serotonergic systems, and the corticotropic axis axis in SHR and WKY rats. Neuropharmacology 1999, 38:893-907.
12. Ek M., Arias C., Sawchenko P., Ericsson-Dahlstrand A. Distribution of the EP3 prostaglandin E(2) receptor subtype in the rat brain: relationship to sites of interleukin-1-induced cellular responsiveness. J. Comp. Neurol. 2000, 428:5-20.
13. Ek M., Engblom D., Saha S., Blomqvist A., Jakobsson P.J., Ericsson-Dahlstrand A. Inflammatory response: pathway across the blood-brain barrier. Nature 2001, 410:430-431.
14. Ek M., Kurosawa M., Lundeberg T., Ericsson A. Activation of vagal afferents after intravenous injection of interleukin-1beta: role of endogenous prostaglandins. J. Neurosci. 1998, 18:9471-9479.
15. Engstrom L., Rosen K., Angel A., Fyrberg A., Mackerlova L., Konsman J.P., Engblom D., Blomqvist A. Systemic immune challenge activates an intrinsically regulated local inflammatory circuit in the adrenal gland. Endocrinology 2008, 149:1436-1450.
16. Ericsson A., Kovács K.J., Sawchenko P.E. A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons. J. Neurosci. 1994, 14:897-913.
17. Ferrario P., Bianchi M. Simultaneous determination of nimesulide and hydroxynimesulide in rat plasma, cerebrospinal fluid and brain by liquid chromatography using solid-phase extraction. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2003, 785:227-236.
18. Fujino H., Xu W., Regan J.W. Prostaglandin E2 induced functional expression of early growth response factor-1 by EP4, but not EP2, prostanoid receptors via the phosphatidylinositol 3-kinase and extracellular signal-regulated kinases. J. Biol. Chem. 2003, 278:12151-12156.
19. Garcia-Bueno B., Serrats J., Sawchenko P.E. Cerebrovascular cyclooxygenase-1 expression, regulation, and role in hypothalamic-pituitary-adrenal axis activation by inflammatory stimuli. J. Neurosci. 2009, 29:12970-12981.
20. Ghersi-Egea J.F., Finnegan W., Chen J.L., Fenstermacher J.D. Rapid distribution of intraventricularly administered sucrose into cerebrospinal fluid cisterns via subarachnoid velae in rat. Neuroscience 1996, 75:1271-1288.
21. Herkenham M., Lee H.Y., Baker R.A. Temporal and spatial patterns of c-fos mRNA induced by intravenous interleukin-1: a cascade of non-neuronal cellular activation at the blood-brain barrier. J. Comp. Neurol. 1998, 400:175-196.
22. Huff R., Collins P., Kramer S., Seibert K., Koboldt C., Gregory S., Isakson P. A structural feature of N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulfonamide (NS-398) that governs its selectivity and affinity for cyclooxygenase 2 (COX2). Inflamm. Res. 1995, 44(Suppl 2):S145-146.
23. Kehrer P., Turnill D., Dayer J.M., Muller A.F., Gaillard R.C. Human recombinant interleukin-1 beta and -alpha, but not recombinant tumor necrosis factor alpha stimulate ACTH release from rat anterior pituitary cells in vitro in a prostaglandin E2 and cAMP independent manner. Neuroendocrinology 1988, 48:160-166.
24. Khan A.M., Ponzio T.A., Sanchez-Watts G., Stanley B.G., Hatton G.I., Watts A.G. Catecholaminergic control of mitogen-activated protein kinase signaling in paraventricular neuroendocrine neurons in vivo and in vitro: a proposed role during glycemic challenges. J. Neurosci. 2007, 27:7344-7360.
25. Konsman J.P., Kelley K., Dantzer R. Temporal and spatial relationships between lipopolysaccharide-induced expression of Fos, interleukin-1beta and inducible nitric oxide synthase in rat brain. Neuroscience 1999, 89:535-548.
26. Konsman J.P., Luheshi G.N., Bluthe R.M., Dantzer R. The vagus nerve mediates behavioural depression, but not fever, in response to peripheral immune signals; a functional anatomical analysis. Eur. J. Neurosci. 2000, 12:4434-4446.
27. Konsman J.P., Vigues S., Mackerlova L., Bristow A., Blomqvist A. Rat brain vascular distribution of interleukin-1 type-1 receptor immunoreactivity: relationship to patterns of inducible cyclooxygenase expression by peripheral inflammatory stimuli. J. Comp. Neurol. 2004, 472:113-129.
28. Lacroix S., Rivest S. Effect of acute systemic inflammatory response and cytokines on the transcription of the genes encoding cyclooxygenase enzymes (COX-1 and COX-2) in the rat brain. J. Neurochem. 1998, 70:452-466.
29. Li S., Ballou L.R., Morham S.G., Blatteis C.M. Cyclooxygenase-2 mediates the febrile response of mice to interleukin-1beta. Brain Res. 2001, 910:163-173.
30. Luheshi G., Miller A.J., Brouwer S., Dascombe M.J., Rothwell N.J., Hopkins S.J. Interleukin-1 receptor antagonist inhibits endotoxin fever and systemic interleukin-6 induction in the rat. Am. J. Physiol. 1996, 270:E91-95.
31. Matsumura K., Kaihatsu S., Imai H., Terao A., Shiraki T., Kobayashi S. Cyclooxygenase in the vagal afferents: is it involved in the brain prostaglandin response evoked by lipopolysaccharide?. Auton. Neurosci. 2000, 85:88-92.
32. McCarthy D.O., Daun J.M. The role of prostaglandins in interleukin-1 induced gastroparesis. Physiol. Behav. 1992, 52:351-353.
33. Nadjar A., Combe C., Busquet P., Dantzer R., Parnet P. Signaling pathways of interleukin-1 actions in the brain: anatomical distribution of phospho-ERK1/2 in the brain of rat treated systemically with interleukin-1beta. Neuroscience 2005, 134:921-932.
34. Newton R.C., Uhl J., Covington M., Back O. The distribution and clearance of radiolabeled human interleukin-1 beta in mice. Lymphokine Res. 1988, 7:207-216.
35. Okumura T., Murata Y., Hizue M., Matsuura T., Naganeo R., Kanai Y., Murase A., Sakakibara A., Fujita I., Nakao K. Pharmacological separation between peripheral and central functions of cyclooxygenase-2 with CIAA, a novel cyclooxygenase-2 inhibitor. Eur. J. Pharmacol. 2006, 539:125-130.
36. Parsadaniantz S.M., Lebeau A., Duval P., Grimaldi B., Terlain B., Kerdelhue B. Effects of the inhibition of cyclo-oxygenase 1 or 2 or 5-lipoxygenase on the activation of the hypothalamic-pituitary-adrenal axis induced by interleukin-1beta in the male rat. J. Neuroendocrinol. 2000, 12:766-773.
37. Proescholdt M.G., Chakravarty S., Foster J.A., Foti S.B., Briley E.M., Herkenham M. Intracerebroventricular but not intravenous interleukin-1beta induces widespread vascular-mediated leukocyte infiltration and immune signal mRNA expression followed by brain-wide glial activation. Neuroscience 2002, 112:731-749.
38. Proescholdt M.G., Hutto B., Brady L.S., Herkenham M. Studies of cerebrospinal fluid flow and penetration into brain following lateral ventricle and cisterna magna injections of the tracer [14C]inulin in rat. Neuroscience 2000, 95:577-592.
39. Reyes T.M., Sawchenko P.E. Involvement of the arcuate nucleus of the hypothalamus in interleukin-1-induced anorexia. J. Neurosci. 2002, 22:5091-5099.
40. Rivest S. What is the cellular source of prostaglandins in the brain in response to systemic inflammation? Facts and controversies. Mol. Psychiatry 1999, 4:500-507.
41. Rivier C., Chizzonite R., Vale W. In the mouse, the activation of the hypothalamic-pituitary-adrenal axis by a lipopolysaccharide (endotoxin) is mediated through interleukin-1. Endocrinology 1989, 125:2800-2805.
42. Roh M.S., Drazenovich K.A., Barbose J.J., Dinarello C.A., Cobb C.F. Direct stimulation of the adrenal cortex by interleukin-1. Surgery 1987, 102:140-146.
43. Romanovsky A.A., Ivanov A.I., Karman E.K. Blood-borne, albumin-bound prostaglandin E2 may be involved in fever. Am. J. Physiol. 1999, 276:R1840-1844.
44. Saper C.B., Reis D.J., Joh T. Medullary catecholamine inputs to the anteroventral third ventricular cardiovascular regulatory region in the rat. Neurosci. Lett. 1983, 42:285-291.
45. Sawchenko P.E., Swanson L.W. The organization of noradrenergic pathways from the brainstem to the paraventricular and supraoptic nuclei in the rat. Brain Res. 1982, 257:275-325.
46. Schiltz J.C., Sawchenko P.E. Distinct brain vascular cell types manifest inducible cyclooxygenase expression as a function of the strength and nature of immune insults. J. Neurosci. 2002, 22:5606-5618.
47. Schwartz M.W., Woods S.C., Porte D., Seeley R.J., Baskin D.G. Central nervous system control of food intake. Nature 2000, 404:661-671.
48. Shu S.Y., Ju G., Fan L.Z. The glucose oxidase-DAB-nickel method in peroxidase histochemistry of the nervous system. Neurosci. Lett. 1988, 85:169-171.
49. Swiergiel A.H., Dunn A.J. Distinct roles for cyclooxygenases 1 and 2 in interleukin-1-induced behavioral changes. J. Pharmacol. Exp. Ther. 2002, 302:1031-1036.
50. Torre D., Zeroli C., Giola M., Fiori G.P., Nespoli L., Daverio A., Ferrario G., Martegani R. Acute-phase proteins and levels of interleukin 1B, interleukin 6, tumor necrosis factor alpha, and interleukin 8 in children with pertussis. Am. J. Dis. Child. 1993, 147:27-29.
51. Waschbisch A., Fiebich B.L., Akundi R.S., Schmitz M.L., Hoozemans J.J., Candelario-Jalil E., Virtainen N., Veerhuis R., Slawik H., Yrjanheikki J., Hull M. Interleukin-1 beta-induced expression of the prostaglandin E-receptor subtype EP3 in U373 astrocytoma cells depends on protein kinase C and nuclear factor-kappaB. J. Neurochem. 2006, 96:680-693.
52. Yamamoto T., Nozaki-Taguchi N. Analysis of the effects of cyclooxygenase (COX)-1 and COX-2 in spinal nociceptive transmission using indomethacin, a non-selective COX inhibitor, and NS-398, a COX-2 selective inhibitor. Brain Res. 1996, 739:104-110.
53. Yamamoto T., Nozaki-Taguchi N. The role of cyclooxygenase-1 and -2 in the rat formalin test. Anesth. Analg. 2002, 94:962-967.
54. Zanetti G., Heumann D., Gérain J., Kohler J., Abbet P., Barras C., Lucas R., Glauser M.P., Baumgartner J.D. Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice. Comparative protective efficacy of antibodies to tumor necrosis factor-alpha and to lipopolysaccharide. J. Immunol. 1992, 148:1890-1897.
55. Zhang J., Rivest S. Distribution, regulation and colocalization of the genes encoding the EP2- and EP4-PGE2 receptors in the rat brain and neuronal responses to systemic inflammation. Eur. J. Neurosci. 1999, 11:2651-2668.